Photo - SYTE.bio
52375

SYTE.bio

DNA Precision Therapeutics

Argentina
Market: Medicine
Stage of the project: Prototype or product is ready

Date of last change: 28.05.2021
Show contacts
1
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

We develop linear DNA based precision therapeutics as Vaccines for Infectious Diseases and Cancer and Gene Therapies for genetic disorders

Current Status

We are a pre-clinical stage company that develops DNA based therapeutics for several diseases. We have develped SARS-CoV-2 and Dengue DNA based vaccine candidates with promising in-vitro and in-vivo proof of concept results. As well we have also developed a novel approach to Melanoma Treatment with great in-vivo canine and feline case reports.

Problem or Opportunity

We do not use viral systems for gene delivery. We only use DNA + Liposomes for gene delivery and therapeutic effects for Infectious Diseases such as Dengue Virus and Cancer such as melanoma that are neglected diseases with no preventive or treatment therapeutics

Solution (product or service)

We develop linear DNA based therapeutics for Infectious diseases such as COVID-19 and Dengue and for Oncology, specifically for Melanoma and Squamous Cell Carinoma. We have performed several proof of concept assays for our candidates with very promising results.

Competitors

There are competitors that produce DNA based therapeutics as INOVIO but the main difference is that they use plasmidic circular DNA and we use linear DNA devoided of bacterial genetic elements

Advantages or differentiators

We differenciate from our competitors because we use non viral genetic sequences for vaccine and gene therapy development.
As well these types of molecules are produced in bacteria at lower prices than viral systems and are more efficient as well

Money will be spent on

The money will be spent on FDA guided pre-clinical trials, patenting, salaries and Phase I small clinical trial

Offer for investor

We are open for discussing an offer for the investor

Team or Management

Won the competition and other awards

We have won several competitions and prices:

2018 - ALL-TEC Competition - Argentina Biotechnology Innovation Award US$ 13.000 Funded

2019 - YPFtec - Argentina Science Ministry Biotechnology Innovation Award

2020 - Argenitna Science Ministry and Spain Fomento San Sebastian
Biotechnology Innovation Award US$ 3.000 Funded

Invention/Patent

We are currently filling the patent paperwork

Photos

Photo 1 - DNA Precision Therapeutics
3,50
1
2
3
4
5
2 voices
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility244
star0
Add to favorites
Delete from favorites
share
close
thumb_up2
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video